Novel Delivery Technology for Medical Countermeasures
Abstract
The DoD requires rapid development of medical countermeasures (MCM) to ensure force health protection and improve our ability to respond to emerging and novel biological threats. Despite recent advancements in development of new MCMs, challenges with delivery limits their current therapeutic potential. While emerging targeted delivery systems such as polymer/lipid nanoparticles and viral vectors have enabled the delivery of large, complex MCM molecules, they are still plagued by lack of widespread availability and effectiveness. Investing in efficient, adaptable delivery technology is crucial for strengthening biosecurity preparedness, and will enable rapid response to the evolving biological threat landscape, whether the threat is natural or manmade. The Novel Delivery Technology for Medical Countermeasures program will develop minimally invasive MCM delivery systems, in which any therapeutic can be quickly formulated and administered to treat or prevent any disease. Developing novel delivery platforms will maintain warfighter health and readiness and enable rapid response to existing and novel biothreats.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2025
- Source ID
- 1b118c6c6e6ca8a2725a9cb999213a9e
Related Documents
- Root: BIOMEDICAL TECHNOLOGY